Dalazatide TFA

Catalog Number Pack Size List Price* Quantity
HY-P3507A-1MG 1 mg 722,00 Add
HY-P3507A-5MG 5 mg 1'949,00 Add
HY-P3507A-10MG 10 mg 3'240,00 Add

* CHF, excl. 7.7% VAT and shipping costs

Product Description

Best price guarantee – we offer you the lowest price in Switzerland. Please contact us for a quote if needed.

ShK-186 TFA
Dalazatide (ShK-186) TFA is a specific Kv1.3 potassium channel peptide inhibitor. Dalazatide TFA can be used in the study of autoimmune diseases such as multiple sclerosis (MS), lupus erythematosus, psoriasis, rheumatoid arthritis, type 1 diabetes and inflammatory bowel disease.

Category Peptide
Supplier MedChem Express
Regulatory Status RUO
Research Field Metabolic Disease, Inflammation/Immunology, Membrane Transporter/Ion Channel
Grade Clinical information: No Development Reported
Purity 98.44%
Storage Conditions Sealed storage, away from moisture; Powder -80°C 2 years, -20°C 1 year; In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)
Tech. Data Sheet View datasheet
Link To Supplier http://www.medchemexpress.com
Shipping Details Room temperature
Material Safety Data Sheet Download PDF